Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.
The first rapid prototyping therapeutics company
Andes develops an integrated microbial technology to help accelerate crop growth.
Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
Hi Fidelity Genetics is a start up based in Durham, NC.
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.
MacroCycle Technologies is a cleantech company that develops sustainable and zero-carbon plastic upcycling solutions.
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.
Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.
Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials.
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
PHNX Materials is a manufacturing company that specializes in turning waste into essential materials and reduce carbon emissions.
Reverb Therapeutics engages in the development of treatments for cancer and other diseases.
Rarebird is a coffee company featuring Arabica coffee beans that deliver improved mental wellness outcomes.
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.
Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.
Cypris Materials is a developer of color for the paints, inks, and coatings sectors.
Canaery is builds a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds.
KdT Ventures has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
KdT Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 34 different industry categories.
Among tracked funding rounds, Parthenon Therapeutics received $65.0M in a Series A round. KdT Ventures's total known invested capital is $805.4M.
KdT Ventures's average investment size is $14.1M across its portfolio of 57 companies.
Recent KdT Ventures portfolio additions include Transcera, SURGE Therapeutics, Unravel Biosciences, Andes, Checkerspot. These companies were founded in 2020 or later.